(Q38190096)

PubMed publication ID

30 August 2017

1 reference

title

Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837416&resulttype=core&format=json

12 May 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837416&resulttype=core&format=json

12 May 2020

author name string

Sih Min Tan

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837416&resulttype=core&format=json

12 May 2020

publication date

21 February 2014

1 reference

PubMed publication ID

30 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837416&resulttype=core&format=json

12 May 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837416&resulttype=core&format=json

12 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837416&resulttype=core&format=json

12 May 2020

page(s)

107-117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837416&resulttype=core&format=json

IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030

12 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Biochemistry and molecular cell biology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Oxidative stress and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Defective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

The response of antioxidant genes to hyperglycemia is abnormal in patients with type 1 diabetes and diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Resveratrol protects diabetic kidney by attenuating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via Nrf2-Keap1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Prevention of diabetic nephropathy in rats through enhanced renal antioxidative capacity by inhibition of the proteasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Diabetic retinopathy is associated with oxidative stress and mitigation of gene expression of antioxidant enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Reconciling the chemistry and biology of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Vitamin E oxidation in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Effects of vitamins C and E and beta-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Vitamin C intake and cardiovascular disease risk factors in persons with non-insulin-dependent diabetes mellitus. From the Insulin Resistance Atherosclerosis Study and the San Luis Valley Diabetes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Effects of vitamin C supplementation on antioxidants and lipid peroxidation markers in elderly subjects with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Nrf2 activators as attractive therapeutics for diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Nrf2 is critical in defense against high glucose-induced oxidative damage in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Activation of NF-E2-related factor-2 reverses biochemical dysfunction of endothelial cells induced by hyperglycemia linked to vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Therapeutic potential of Nrf2 activators in streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Diabetic downregulation of Nrf2 activity via ERK contributes to oxidative stress-induced insulin resistance in cardiac cells in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

A defect in Nrf2 signaling constitutes a mechanism for cellular stress hypersensitivity in a genetic rat model of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Sulforaphane prevention of diabetes-induced aortic damage was associated with the up-regulation of Nrf2 and its down-stream antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Redox regulation by Nrf2: gatekeeping for the basal and diabetes-induced expression of thioredoxin interacting protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

A preliminary evaluation of bardoxolone methyl for the treatment of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Nrf2-dependent upregulation of antioxidative enzymes: a novel pathway for proteasome inhibitor-mediated cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Ebselen augments its peroxidase activity by inducing nrf-2-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Site-specific antiatherogenic effect of the antioxidant ebselen in the diabetic apolipoprotein E-deficient mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Sulforaphane protects against cytokine- and streptozotocin-induced beta-cell damage by suppressing the NF-kappaB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Resveratrol protects human keratinocytes HaCaT cells from UVA-induced oxidative stress damage by downregulating Keap1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Sirt1 resists advanced glycation end products-induced expressions of fibronectin and TGF-β1 by activating the Nrf2/ARE pathway in glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Resveratrol attenuates early diabetic nephropathy by down-regulating glutathione s-transferases Mu in diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Resveratrol: its biologic targets and functional activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

The ubiquitin-proteasome system contributes to the inflammatory injury in ischemic diabetic myocardium: the role of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Therapeutic effect of MG-132 on diabetic cardiomyopathy is associated with its suppression of proteasomal activities: roles of Nrf2 and NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Potential role for Nrf2 activation in the therapeutic effect of MG132 on diabetic nephropathy in OVE26 diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

MG132, a proteasome inhibitor, induces apoptosis in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

New synthetic triterpenoids: potent agents for prevention and treatment of tissue injury caused by inflammatory and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Dihydro-CDDO-trifluoroethyl amide (dh404), a novel Nrf2 activator, suppresses oxidative stress in cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Analogs of bardoxolone methyl worsen diabetic nephropathy in rats with additional adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Bardoxolone methyl analogs RTA 405 and dh404 are well tolerated and exhibit efficacy in rodent models of Type 2 diabetes and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Cardiac and renal function in patients with type 2 diabetes who have chronic kidney disease: potential effects of bardoxolone methyl

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

The synthetic triterpenoid, RTA 405, increases the glomerular filtration rate and reduces angiotensin II-induced contraction of glomerular mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Synthetic oleanane triterpenoids: magic bullets or not?

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

A phase I first-in-human trial of bardoxolone methyl in patients with advanced solid tumors and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Toward clinical application of the Keap1-Nrf2 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Enhanced Nrf2 activity worsens insulin resistance, impairs lipid accumulation in adipose tissue, and increases hepatic steatosis in leptin-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Adipose deficiency of Nrf2 in ob/ob mice results in severe metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

ROS signaling, oxidative stress and Nrf2 in pancreatic beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Mortality in randomized trials of antioxidant supplements for primary and secondary prevention: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Effects of broccoli sprout with high sulforaphane concentration on inflammatory markers in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

Broccoli sprouts reduce oxidative stress in type 2 diabetes: a randomized double-blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

High Glucose Induces Antioxidant Enzymes in Human Endothelial Cells in Culture: Evidence Linking Hyperglycemia and Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1351000214Y.0000000087

DNA damage induced by resveratrol and its synthetic analogues in the presence of Cu (II) ions: mechanism and structure-activity relationship

21 January 2018

1 reference

12 December 2020

Prevention of diabetic nephropathy by sulforaphane: possible role of Nrf2 upregulation and activation

1 reference

12 December 2020

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

12 December 2020

Plant polyphenol induced cell death in human cancer cells involves mobilization of intracellular copper ions and reactive oxygen species generation: a mechanism for cancer chemopreventive action

1 reference

12 December 2020

Therapeutic effect of MG132 on the aortic oxidative damage and inflammatory response in OVE26 type 1 diabetic mice

1 reference

12 December 2020

Design and synthesis of 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages

1 reference

12 December 2020

Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice.

1 reference

12 December 2020

Novel synthetic oleanane triterpenoids: a series of highly active inhibitors of nitric oxide production in mouse macrophages

1 reference

12 December 2020

Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD

1 reference

12 December 2020

10.1179/1351000214Y.0000000087

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837416&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6837416&resulttype=core&format=json

12 May 2020

PubMed publication ID

24559141

1 reference